Top Markets
#1 Black Phoenix Black Phoenix +354.04%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +69.28%
#4 Gold Park Gold Park +58.04%
#5 Acurast Acurast +39.30%
#6 OpenEden OpenEden +35.14%
#7 BasedHype BasedHype +27.14%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.38%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +17.76%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Rank in Stocks #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Share Price
$0.13607016
Last synced: 2024-09-10
Market Cap
$112.29K
Change (1 day)
22.46%
Change (1 year)
0.00%
Country
GB
Trade BiVictriX Therapeutics Plc (BVX)

Category

Healthcare
Earnings for BiVictriX Therapeutics Plc (BVX)
Earnings in 2026 TTM: 0
According to BiVictriX Therapeutics Plc latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for BiVictriX Therapeutics Plc from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE